NCT04105205View on ClinicalTrials.gov

First-In-Human Study of Apramycin

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

July 16, 2020

Study Completion Date

October 16, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

Apramycin injection

30-min infusion

DRUG

Placebo injection

30-min infusion

Trial Locations (1)

Unknown

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Innovative Medicines Initiative

OTHER

lead

Juvabis AG

INDUSTRY